Zinplava ™ (bezlotoxumab) injection will be discontinued as of January 31, 2025, according to the Food and Drug Administration’s (FDA) drug shortages tracker.

An expert panel consisting of dietitians, doctors, nutritional epidemiologists, chefs, and weight loss researchers examined ...

The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...

For the fifth consecutive year, Congress has adjourned and allowed Medicare cuts,” said Bruce A. Scott, MD, president of the AMA.

(HealthDay News) — Prenatal exposure to glucocorticoids is associated with some mental disorders in offspring, such as mood, anxiety, and stress-related disorders, according to a study published ...

Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

The application is supported by data from the randomized, double-blind, placebo-controlled phase 3 Vivacity-MG3 study.

The OraQuick HIV Self-Test is an in-vitro diagnostic home-use antibody test that utilizes oral fluid to determine whether a patient has been exposed to HIV.

Posdinemab works by targeting and neutralizing Alzheimer disease-specific phosphorylated tau, preventing its spread to other neurons.

Multidisciplinary collaborative approach to care is required for patients with hematological malignancies in pregnancy.

Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable, procedureless intragastric balloon, in adults with obesity.